Cargando…
Tolerable treatment of glioblastoma with redox-cycling ‘mitocans': a comparative study in vivo
Objectives: The present study describes a pharmacological strategy for the treatment of glioblastoma by redoxcycling ‘mitocans’ such as quinone/ascorbate combination drugs, based on their tumor-selective redox-modulating effects and tolerance to normal cells and tissues. Methods: Experiments were pe...
Autores principales: | Sumiyoshi, Akira, Shibata, Sayaka, Lazarova, Dessislava, Zhelev, Zhivko, Aoki, Ichio, Bakalova, Rumiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435007/ https://www.ncbi.nlm.nih.gov/pubmed/37581329 http://dx.doi.org/10.1080/13510002.2023.2220531 |
Ejemplares similares
-
Redox-Cycling “Mitocans” as Effective New Developments in Anticancer Therapy
por: Bakalova, Rumiana, et al.
Publicado: (2023) -
Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State
por: Sumiyoshi, Akira, et al.
Publicado: (2022) -
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
por: Zhelev, Zhivko, et al.
Publicado: (2022) -
Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant
por: Bakalova, Rumiana, et al.
Publicado: (2020) -
“Redox Imaging” to Distinguish Cells with Different Proliferative Indexes: Superoxide, Hydroperoxides, and Their Ratio as Potential Biomarkers
por: Zhelev, Zhivko, et al.
Publicado: (2019)